English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  52959179    在线人数 :  820
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"許駿"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 36-45 / 148 (共15页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
國立臺灣大學 2014 Development of GADD45 beta (growth arrest DNA damage-inducible gene 45 beta) agonists for the treatment of hepatocellular carcinoma (HCC) Hsu, Chiun; Ou, Da-Liang; Chen, Kuen-Feng; Lin, Zhong-Zhe; Cheng, Ann-Lii; Shiau, Chung-Wai; 林宗哲; 鄭安理; 許駿; 陳昆鋒; 歐大諒
國立臺灣大學 2014 Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma Chang, Ming-Chu; Chen, Chien-Hung; Liang, Ja-Der; Tien, Yu-Wen; Hsu, Chiun; Wong, Jau-Min; Chang, Yu-Ting; 翁昭旼; 許駿; 章明珠; 田郁文; 陳健弘; 張毓廷; 梁嘉德
國立臺灣大學 2014 Strategy for Preventing Hepatitis B Reactivation in Patients With Resolved Hepatitis B Virus Infection After Rituximab-Containing Chemotherapy Reply Hsu, Chiun; Chen, Pei-Jer; Cheng, Ann-Lii; 鄭安理; 許駿
國立臺灣大學 2014 PREVENTION OF CHEMOTHERAPY-INDUCED HBV-RELATED HEPATITIS FLARE IN LYMPHOMA PATIENTS WITH RESOLVED HBV INFECTION: COST ANALYSIS Tsou, H. -H.; Yang, H. -C.; Chuang, M. -H.; Wu, H. -Y.; Hsu, Y. -T.; Chang, W. -J.; Hsiao, C. -F.; Hsu, C.; 許駿
國立臺灣大學 2013 14-3-3 epsilon Overexpression Contributes to Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Liu, Tzu-An; Jan, Yee-Jee; Ko, Bor-Sheng; Liang, Shu-Man; Chen, Shyh-Chang; Wang, John; Hsu, Chiun; Wu, Yao-Ming; Liou, Jun-Yang; 柯博升; 許駿; 吳耀銘
國立臺灣大學 2013 Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients Chen, I. C.; Hsu, C.; Chen, Y. C.; Chien, S. F.; Kao, H. F.; Chang, S. Y.; Hu, F. C.; Yeh, K. H.; 許駿; 葉坤輝; 陳宜君
國立臺灣大學 2013 Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: a meta-analysis and meta-regression (vol 15, pg 265, 2012) Hsu, Chiun; Shen, Ying-Chun; Cheng, Chia-Chi; Cheng, Ann-Lii; Hu, Fu-Chang; Yeh, Kun-Huei; 鄭安理; 許駿; 葉坤輝
國立臺灣大學 2013 Bevacizumab with Erlotinib as First-line Therapy in Asian Patients with Advanced Hepatocellular Carcinoma: A Multicenter Phase II Study Hsu, Chih-Hung; Kang, Yoon Koo; Yang, Tsai-Shen; Shun, Chia-Tung; Shao, Yu-Yun; Su, Wu-Chou; Sandoval-Tan, Jennifer; Chiou, Tzeon-Jye; Jin, Kate; Hsu, Chiun; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏; 許駿; 孫家棟
國立臺灣大學 2013 Potentiating the Efficacy of Molecular Targeted Therapy for Hepatocellular Carcinoma by Inhibiting the Insulin-Like Growth Factor Pathway Ou, Da-Liang; Lee, Bin-Shyun; Chang, Ya-Chi; Lin, Liang-In; Liou, Jun-Yang; Hsu, Chiun; Cheng, Ann-Lii; 林亮音; 鄭安理; 許駿; 歐大諒
國立臺灣大學 2013 The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines Chen, Wei-Wu; Chang, Dwan-Ying; Huang, Shu-Min; Lin, Ching-Hung; Hsu, Chun; Lin, Ming-Hwai; Huang, Chiun-Shen; Lu, Yen-Shen; Cheng, Ann-Lii; 陳偉武; 盧彥伸; 鄭安理; 許駿; 黃俊升; 張端瑩; 林璟宏

显示项目 36-45 / 148 (共15页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目